Vfend Tablet, Film Coated
Product Images NDC 0049-3170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Vfend (NDC 0049-3170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Vfend 02)
Principal Display Panel (50 mg Tablet Bottle Label)
Principal Display Panel (200 mg Tablet Bottle Label)
Principal Display Panel (200 mg Vial Label)
Principal Display Panel (200 mg Vial Carton)
Principal Display Panel (40 mg Bottle Label)
Principal Display Panel (40 mg Bottle Carton)
Vfend 09
Vfend 10
Vfend 11
Vfend 12
Vfend 13
Vfend 14
Vfend 15
This is a medication called Vfend (voriconazole) and is sold as 30 tablets. It should be stored in a controlled room temperature between 16°C to 30°C and dispensed in n gt cataers dosage. It is distributed by a company called Refrigeration Division of Pfizer and made in Ireland. This information is accompanied by a lot number (567801), drug code (D DC 004931700), and an ETFl 8 code.*
Vfend 16
Product name: Voriconazole Tablets 200mg. These are controlled room temperature tablets that should be stored at a temperature range between 15°C to 30°C (59°F to 86°F). The package contains 30 tablets, each containing 200mg Voriconazole. The usage and dosage information for these tablets are available with the prescription. This product is distributed by Roerig, a division of Pfizer. The tablets are made in Ireland.*
Vfend 17
This is a medication instruction for Voriconazole, which is used for intravenous infusion after dilution. The medication needs to be stored at a controlled room temperature between 15°C to 30°C. Each mL contains 10 mg Voriconazole and 160 mg sulfobutyl ether B-cyclodextrin sodium (SBECD). It is distributed by Roerig, Pfizer Inc. in New York, USA. The location of manufacturing is Ireland. Lot and Expiry dates are mentioned in the end.*
Vfend 18
Vfend® LV is a sterile, single-dose vial containing 200mg of voriconazole for intravenous infusion only. It should be reconstituted with 19mL of Water for Injection to give a clear solution containing 10mg/mL. It can then be further diluted and added to recommended compatible infusion solutions to provide a final solution containing 0.5mg/mL. For appropriate directives and storage recommendations, the prescribing information should be referred to. This product is made in Ireland and is not made with natural rubber latex. Discard unused portion.*
Vfend 19
This is a medication containing 3 grams of voriconazole and is intended for oral use only. The dry powder should be stored in the refrigerator at 2-8 degrees Celsius, and after reconstitution, the suspension should be kept at room temperature between 15-30 degrees Celsius. Any unused suspension should be discarded after 14 days. Mixing the powder with water and shaking vigorously for a minute can prepare the suspension. Each millilitre of the oral suspension contains 40 mg of voriconazole. Dosage and use instructions are not provided, and the medication is distributed by Roerig, Division of Pfizer Inc., NY, NY 10017. The lot number and expiration date are also mentioned.*
Vfend 20
This text provides detailed instructions and information about the use of Vfend® (voriconazole), an oral suspension used for the treatment of fungal infections. The text includes instructions for reconstitution, storage, and proper dosage. It also includes details about the manufacturer and distribution of the product, cautionary instructions, and product labeling information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.